Showing 3,621 - 3,640 results of 3,808 for search 'significant ((((((step decrease) OR (nn decrease))) OR (greatest decrease))) OR (mean decrease))', query time: 0.37s Refine Results
  1. 3621

    Figure 2 from Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in <i>EGFR</i>- and <i>KRAS</i>-Mutant Lung Cancer by Xiaoxiao Sun (20589448)

    Published 2025
    “…<p>PRMT1 knockdown decreases persistence in STAT1-high <i>EGFR</i><sup><i>mut</i></sup> and <i>KRAS</i><sup><i>G12C</i></sup> lung cancer cell lines. …”
  2. 3622

    Table 2_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  3. 3623

    Image 3_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  4. 3624

    Table 1_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  5. 3625

    Image 2_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  6. 3626

    Table 3_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  7. 3627

    Image 1_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  8. 3628

    Image 8_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tif by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  9. 3629

    Image 6_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  10. 3630

    Image 4_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tif by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  11. 3631

    Image 7_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  12. 3632

    Image 5_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  13. 3633

    Table 4_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  14. 3634

    Table 5_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

    Published 2025
    “…The SUVRs were calculated using the standard methodology, where the mean standardized uptake value (SUV) of each region of interest (ROI) was divided by the mean SUV of the reference region, that is the whole cerebellum. …”
  15. 3635

    Data Sheet 1_Prevalence trends, population characteristics and treatment outcomes of tuberculosis combined with diabetes in Southwest China: a register-based retrospective study.do... by Deliang Kong (382201)

    Published 2024
    “…PTB-DM patients were characterized by a higher proportion of males and older adult individuals, the age range of the patients was 11 ~ 100 years, with a mean age of 58.21 ± 12.02 years, with multiple positive aetiological results, and lower rates of proactive medical consultation. …”
  16. 3636

    Altered spatial distribution of EPDCs in <i>Wt1</i><sup>Cre</sup>; <i>Sox9</i><sup>fl/fl</sup>; <i>R26</i><sup>mG</sup> hearts. by Andrew B. Harvey (21587431)

    Published 2025
    “…Chi-square analysis indicates a significant shift in spatial distribution (p < 0.0001). …”
  17. 3637

    MLN IFN- by Jessica Belmares-Ortega (21212731)

    Published 2025
    “…<p><b>γ</b><b>production is decreased in the absence of MyD88 and</b><b>αβ</b><b>T cells.…”
  18. 3638

    Reduced expression of MYBPC3 mRNA and cMyBP-C protein in the proband. by Yuanyuan Zhang (101797)

    Published 2025
    “…<p>(A) RT-qPCR analysis showing significantly decreased MYBPC3 mRNA levels in cardiac sample from the proband compared to control subjects. …”
  19. 3639

    The effect of IFN-β and Vit D on the IL-1β and IL-10 protein production. by Farzad Nasri (8941850)

    Published 2025
    “…IFN-β and Vit D alone or together decreased IL-1β and IL-10 protein level, significantly in comparison with the control <b>(A, B)</b>. …”
  20. 3640

    Therapeutic Administration Success Rates. by Alani Mohanad Khalid Ahmed (22693496)

    Published 2025
    “…<p>Bar chart representing the Mean Therapeutic Administration Success Rates for the control group, treated groups (BM-MSC1, BM-MSC2, AD-MSC1, AD-MSC2), and untreated groups (Un-BM1, Un-BM2, Un-AD1, Un-AD2). …”